Efficacy and Safety of Clinical-Grade Human Vascular Endothelial Growth Factor-D(ΔNΔC) Gene Therapy Containing Residual Replication-Competent Adenoviruses.
- DOI
- 10.1089/hum.2020.299
- Published
- 2021 Jul
- Container
- Human gene therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1089/hum.2020.299,
title = {Efficacy and Safety of Clinical-Grade Human Vascular Endothelial Growth Factor-D(ΔNΔC) Gene Therapy Containing Residual Replication-Competent Adenoviruses.},
author = {Leikas AJ and Laham-Karam N and Agtereek E and Peltonen HM and Selander T and Korpisalo P and Holappa L and Hartikainen JEK and Heikura T and Ylä-Herttuala S},
year = {2021},
journal = {Human gene therapy},
doi = {10.1089/hum.2020.299},
url = {https://doi.org/10.1089/hum.2020.299}
}RIS
TY - JOUR TI - Efficacy and Safety of Clinical-Grade Human Vascular Endothelial Growth Factor-D(ΔNΔC) Gene Therapy Containing Residual Replication-Competent Adenoviruses. AU - Leikas AJ AU - Laham-Karam N AU - Agtereek E AU - Peltonen HM AU - Selander T AU - Korpisalo P AU - Holappa L AU - Hartikainen JEK AU - Heikura T AU - Ylä-Herttuala S PY - 2021 JO - Human gene therapy DO - 10.1089/hum.2020.299 UR - https://doi.org/10.1089/hum.2020.299 ER -
APA
AJ, L., N, L., E, A., HM, P., T, S., P, K., L, H., JEK, H., T, H., & S, Y. (2021). Efficacy and Safety of Clinical-Grade Human Vascular Endothelial Growth Factor-D(ΔNΔC) Gene Therapy Containing Residual Replication-Competent Adenoviruses.. Human gene therapy. https://doi.org/10.1089/hum.2020.299
Source records
- pubmed · retrieved 2026-09-25T06:53:11.115Z